Navigation Links
Sutherland Pleads Guilty and Convicted

Dr Trey Sutherland, a government employee of the National Institutes of Health, United States, has finally pleaded guilty to charges// of conflict -of –interests. This involves going against the ethics of the organization by offering professional advice and help to a private company.

Sutherland, a well known Alzheimer researcher was accused of proving the giant drug company, Pfizer with thousands of invaluable blood plasma and tissue samples of Alzheimer patients, as well as pocketing around $300,000 in terms of consultation fees. His research involved the study of ‘biomarkers’; essential characteristics found in the blood and cerebral spinal fluid of Alzheimer patients. Biomarkers reveal the presence and progress of the disease.

Alzheimer’s disease causes mental deterioration leading to confusion, loss of memory and behavioral and health problems.

Sutherland had sought to refrain from answering questions when primarily accused six months ago.

Having being pronounced guilty, Sutherland faces a sentence of 400 hours of community service, two years probation and surrender of the consultation fees.

“Dr. Sunderland violated the fundamental rule that government employees cannot accept payment from interested private parties without the permission of their supervisors," U.S. Attorney Rod Rosenstein said in a statement.

Officials of NIH however, say Sutherland is still an employee of the organization.

'"/>




Page: 1

Related medicine news :

1. Doctor Pleads Not Guilty
2. 10-year-old Pleads, Herceptin For My Mum, Please
3. Extend Workers Compensation To Firefighters. Pleads Son
4. TB Patient Pleads President for Mercy Killing
5. Doctor Pleads Not Guilty
6. Australian Court Finds Man Guilty of Spreading HIV/AIDS
7. GP Found Guilty Of Misconduct
8. Mother Guilty of Transferring HIV to her Child
9. NZ Doctor Found Guilty Of Professional Misconduct
10. Bay of Plenty Pharmacist Found Guilty
11. Six Medicos in Libyan HIV Case Plead Not Guilty
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... Over 40 ... convened in the state capitol for the annual “Hike to Harrisburg” advocacy day. ... and The Winter Group, PATS lobby Group. The goal for the day was ...
(Date:5/4/2016)... ... ... , a leading provider of barcode and RFID labels has acquired ... to continue to grow its label business, customer base and market share. , Netc ... print and label tape media on site and on an as needed basis. Many of ...
(Date:5/3/2016)... ... May 03, 2016 , ... ProIntro Glitch is a set of ... Film Studios’ titles allow users to add a terrifying opener to any video or ... lines and accents. To add greater contrast, all the user has to do is ...
(Date:5/3/2016)... ... May 03, 2016 , ... Sue Desmond-Hellmann, chief executive officer ... to stretch the limits of human possibility in her keynote address at Georgia State ... Georgia Dome. , Drawing on her rich experience as a scientist, physician and executive, ...
(Date:5/3/2016)... ... May 03, 2016 , ... Calvary Hospital recently hosted a reception to ... a 10-bed unit located at Mary, Manning Walsh Home (MMW) in Manhattan. , ... DGH for half an hour, once a week. The music brings a lot of ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... YORK , May 2, 2016 Kalorama ... EMR (Electronic Medical Records) market in a recent white ... sales, vendor switches, Increased physician usage, a growing market are ... were noted in Kalorama,s report EMR 2016: ... report marks Kalorama,s seventh complete study of the EMR ...
(Date:5/2/2016)... NEW YORK , May 2, 2016 /PRNewswire/ ... Series B financing of Graybug Vision, Inc. Graybug ... to developing therapies that may transform care for ... and glaucoma.  Graybug Vision,s technology was first developed ... out into a startup venture. ...
(Date:5/2/2016)... LAWRENCEVILLE, N.J. , May 2, 2016 /PRNewswire/ ... drug development company, today announced data from the ... dose escalating clinical trial (the OVATION Study) combining ... of care for the treatment of newly-diagnosed patients ... chemotherapy followed by interval debulking surgery.  In the ...
Breaking Medicine Technology: